Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocular Therapeutix
Pharma
FDA clears Ocular's Dextenza for eye itching from allergies
Dextenza could reach $250 million in peak sales in eye itching associated with allergic conjunctivitis, Jefferies analyst predicts.
Angus Liu
Oct 12, 2021 10:20am
Regeneron scraps sustained-release Eylea alliance with Ocular
Aug 10, 2021 8:45am
Ocular Therapeutix crosses the finish line with eye treatment
Dec 4, 2018 11:15am
Ocular Therapeutix gets second CRL for eye drug
Jul 12, 2017 11:08am
Eye doc calls for more sustained drug delivery systems for ocular surfaces
Sep 13, 2016 12:38am
Valeant, Ocular Therapeutix get CRLs tied to manufacturing
Jul 25, 2016 11:37am
